BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9306324)

  • 1. Direct and indirect pathways of alloantigen recognition: relevance to acute and chronic allograft rejection.
    Hornick P; Lechler R
    Nephrol Dial Transplant; 1997 Sep; 12(9):1806-10. PubMed ID: 9306324
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell Allorecognition Pathways in Solid Organ Transplantation.
    Siu JHY; Surendrakumar V; Richards JA; Pettigrew GJ
    Front Immunol; 2018; 9():2548. PubMed ID: 30455697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the indirect recognition pathway in the development of chronic liver allograft rejection.
    Renna-Molajoni E; Cinti P; Evangelista B; Orlandini AM; Molajoni J; Cocciolo PL; Suciu-Foca N; Cortesini R
    Transplant Proc; 1998 Aug; 30(5):2140-1. PubMed ID: 9723419
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloantigen processing and presentation.
    Tambur AR; Gebel HM
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.
    Benichou G; Tam RC; Soares LR; Popov IA; Garovoy MR; Fedoseyeva EV
    Res Immunol; 1996; 147(6):377-87. PubMed ID: 8903104
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-specific cardiac allograft tolerance without immunosuppression after intrathymic injection of donor alloantigen.
    Goss JA; Nakafusa Y; Flye MW
    Transplant Proc; 1992 Dec; 24(6):2879-80. PubMed ID: 1465981
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of alloantigen-specific cytotoxic and suppressor activities of lymphocytes by intravenous immunization of mice when donor and recipient differ in class II MHC molecule.
    Kronin VV; Anosova NG; Brondz BD; Chernysheva AD; Krivoshein YS; Popov IA
    Mikrobiol Z; 1993; 55(5):51-5. PubMed ID: 7512873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
    Benichou G; Valujskikh A; Heeger PS
    J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II alloantigen induced on corneal endothelium. Role in corneal allograft rejection.
    Donnelly JJ; Orlin SE; Wei ZG; Raber IM; Rockey JH
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1315-20. PubMed ID: 2194989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection.
    Braun MY; McCormack A; Webb G; Batchelor JR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):863-4. PubMed ID: 8442250
    [No Abstract]   [Full Text] [Related]  

  • 11. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect recognition: the role of MHC antigens in graft rejection.
    Gould DS; Auchincloss H
    Immunol Today; 1999 Feb; 20(2):77-82. PubMed ID: 10098326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic mechanisms of hepatic allograft rejection.
    Vierling JM
    Semin Liver Dis; 1992 Feb; 12(1):16-27. PubMed ID: 1570548
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathways of major histocompatibility complex allorecognition.
    Afzali B; Lombardi G; Lechler RI
    Curr Opin Organ Transplant; 2008 Aug; 13(4):438-44. PubMed ID: 18685342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
    Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin and biology of the allogeneic response.
    Lakkis FG; Lechler RI
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.